Peking University People's Hospital
Peking University People's Hospital
Beijing, China68 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cardiopulmonary Exercise Testing-based High-intensity Interval Training For Improving Heart Failure With Preserved Ejection Fraction | HFpEF - Heart Failure With Preserved Ejection Fraction | Recruiting | Not applicable | 2026-09-30 | NCT07693049 | |
| Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants | Valid MeSH Conditiongs | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07840729 | |
| A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension | cardiovascular disorder, hypertensive disorder, resistant hypertension, vascular disorder | Not yet recruiting | Phase 2 | 2026-09-22 | NCT07833098 | |
| Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT | ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; Elderly; Geriatric Assessment | Recruiting | Not stated | 2026-09-15 | NCT06946654 | |
| Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT. | acute myeloid leukemia | Recruiting | Not applicable | 2026-09-14 | NCT06946602 | |
| Haplo-HSCT for Myelofibrosis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Recruiting | Not applicable | 2026-09-14 | NCT06674382 | |
| A Study of SGB-9768 in Patients With Complement-mediated Kidney Diseases | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, complement 3 glomerulopathy, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Active, not recruiting | Phase 2 | 2026-09-04 | NCT06786338 | |
| A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Not yet recruiting | Phase 2 | 2026-08-31 | NCT07755150 | |
| Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis | Moderate to Severe Atopic Dermatitis | Recruiting | Phase 3 | 2026-08-27 | NCT07370909 | |
| A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Not Receiving Positive Airway Pressure (PAP) Therapy | Apnea, Body Weight, Dyssomnias, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Sleep Disorders, Intrinsic, nervous system disorder, nutritional disorder, obesity disorder, obstructive sleep apnea syndrome, overnutrition, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Not yet recruiting | Phase 3 | 2026-08-26 | NCT07787260 | |
| Efficacy and Safety of Roflumilast Foam 0.3% in Trial Participants With Seborrheic Dermatitis | Skin Diseases, Eczematous, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, dermatitis, sebaceous gland disorder, seborrheic dermatitis, skin disorder | Not yet recruiting | Phase 3 | 2026-08-21 | NCT07683806 | |
| A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia. | B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Disease Attributes, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Recruiting | Phase 1 | 2026-08-17 | NCT06927466 | |
| A Study of DA-302168S in Participants With Overweight/Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 3 | 2026-08-06 | NCT07629544 | |
| A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE) | Systemic Lupus Erthematosus | Recruiting | Phase 1 / Phase 2 | 2026-08-06 | NCT07564596 | |
| A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors. | Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-08-06 | NCT05944224 | |
| A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1) | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 3 | 2026-08-03 | NCT07230119 | |
| Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Active, not recruiting | Phase 2 | 2026-07-29 | NCT07733037 | |
| Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis | Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, proteostasis deficiencies | Recruiting | Phase 2 | 2026-07-28 | NCT07335887 | |
| Songling Xuemaikang in Hypertension and Insomnia Evaluation（SHINE） | Dyssomnias, Sleep Disorders, Intrinsic, cardiovascular disorder, hypertensive disorder, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder, vascular disorder | Not yet recruiting | Not applicable | 2026-07-16 | NCT07709442 | |
| A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic disease | Not yet recruiting | Phase 3 | 2026-07-06 | NCT07680829 | |
| A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Phase 1 / Phase 2 | 2026-06-29 | NCT06535412 | |
| Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Not yet recruiting | Not applicable | 2026-06-23 | NCT07662525 | |
| Coated Aldehyde Oxystarch for Protein-Bound Uremic Toxin Reduction in End-Stage Renal Disease | End Stage Renal Disease on Dialysis | Recruiting | Not applicable | 2026-06-17 | NCT07653711 | |
| UBT251 Injection Phase Ⅲ Study (Overweight or Obesity) | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 3 | 2026-06-15 | NCT07648225 | |
| Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study) | Acute-On-Chronic Liver Failure, Digestive System Diseases, Hepatic Insufficiency, acute liver failure, liver disorder, liver failure | Active, not recruiting | Not stated | 2026-05-26 | NCT05129904 |